1. Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma
   Taizo Uchimoto et al, 2023, BJU International CrossRef
2. Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review
   Blessie Elizabeth Nelson et al, 2021, Frontiers in Oncology CrossRef
3. Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma
   Taizo Uchimoto et al, 2022, Urologic Oncology: Seminars and Original Investigations CrossRef
4. Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
   Taizo Uchimoto et al, 2024, Targeted Oncology CrossRef